. 2011 May 20;89(9):632–639. doi: 10.2471/BLT.11.086462

Table 2. Median monitored treatment days and adherence rates, and proportions of patients who were less than 100%, 95% and 80% adherent,^a as assessed by the Medication Event Monitoring System (MEMS), United Republic of Tanzania, 2010.

Patients^a	Monitored days	Adherence rate (%)	< 100% adherent	< 95% adherent	< 80% adherent
Patients^a	Median (IQR)^b	Median (IQR)^b	No. (%)	No. (%)	No. (%)
All (47)	168 (138–172)	98.4 (95.7–100)	33 (70)	10 (21)	1 (2)
Completed treatment (37)	169 (168–180.5)	98.4 (95.7–100)	27 (73)	7 (19)	0 (0)
Defaulters (2)	40.0/113^c	50.0/100^d	1 (50)	1 (50)	1 (50)
Deaths (4)	63 (29.5–104)	98.4 (95.6–99.6)	3 (75)	1 (25)	0 (0)
Study drop outs (4)	33 (21–73)	98.3 (88.4–100)	2 (50)	1 (25)	0 (0)

IQR, interquartile range.

^a Only patients for whom MEMS data were available are included.

^b All values given are medians and IQRs except for the values of the two defaulters.

^c Number of monitored days for defaulter 1 and defaulter 2, respectively.

^d Adherence rates of defaulter 1 and defaulter 2, respectively.

Table 2. Median monitored treatment days and adherence rates, and proportions of patients who were less than 100%, 95% and 80% adherent,a as assessed by the Medication Event Monitoring System (MEMS), United Republic of Tanzania, 2010.